Organization | Hope Biosciences

Hope Biosciences Report issue

For profit Phase 2

Founded: Irvine CA United States (2016)

Organization Overview

First Clinical Trial

2018

NCT03691909

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Now

Alternative names

Hope Biosciences | Hope Biosciences Stem Cell Research Foundation

Active Ingredients

Drugs in Phase 2 Trials (3)

allogeneic adipose derived mesenchymal stem cell (23 trials)

autologous bone marrow derived mesenchymal cells (1 trial)

bone marrow derived mesenchymal stem cells (1 trial)

Drugs in Other Trials (1)

autologous adipose-derived mesenchymal stem cells (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Arthritis (Phase 2)

Arthritis, Rheumatoid (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 27
# of Trial APIs: 4